Literature DB >> 18695888

Overexpression of EphA4 gene and reduced expression of EphB2 gene correlates with liver metastasis in colorectal cancer.

Takashi Oshima1, Makoto Akaike, Kazue Yoshihara, Manabu Shiozawa, Naoto Yamamoto, Tsutomu Sato, Nozaki Akihito, Yasuhiko Nagano, Shoich Fujii, Chikara Kunisaki, Nobuyuki Wada, Yasushi Rino, Katsuaki Tanaka, Munetaka Masuda, Toshio Imada.   

Abstract

The Eph receptors, members of a large family of transmembrane receptor tyrosine kinases, play important roles in a variety of biological functions. Recent studies have suggested that EphA4 and EphB2 participate in the growth and development of various carcinomas. This study examined the relationship of EphA4 and EphB2 gene expression to clinicopathological factors, especially metastasis, in patients with colorectal cancer. We studied surgical specimens of cancer tissue and adjacent normal mucosa obtained from 205 patients with untreated colorectal cancer. The relative expression levels of EphA4 and EphB2 mRNA in the specimens were measured by quantitative real-time, reverse-transcription polymerase chain reaction. The relative expression level of EphA4 mRNA was higher in the presence than in the absence of liver metastasis, whereas the relative expression levels of EphB2 mRNA were similar. Analysis of the relationship between clinicopathological features and gene expression showed that high expression of the EphA4 gene and low expression of the EphB2 gene correlated with liver metastasis. There was no correlation between EphA4 and EphB2 gene expression. Our results suggest that overexpression of the EphA4 gene and reduced expression of the EphB2 gene might promote liver metastasis in colorectal cancer. Overexpression of the EphA4 gene and reduced expression of the EphB2 gene may thus be a useful predictor of liver metastasis in patients with colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18695888

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  34 in total

1.  Loss of cell-surface receptor EphB2 is important for the growth, migration, and invasiveness of a colon cancer cell line.

Authors:  Paul V Senior; Benny X Zhang; Steven T F Chan
Journal:  Int J Colorectal Dis       Date:  2010-03-26       Impact factor: 2.571

2.  A breast cancer stem cell niche supported by juxtacrine signalling from monocytes and macrophages.

Authors:  Haihui Lu; Karl R Clauser; Wai Leong Tam; Julia Fröse; Xin Ye; Elinor Ng Eaton; Ferenc Reinhardt; Vera S Donnenberg; Rohit Bhargava; Steven A Carr; Robert A Weinberg
Journal:  Nat Cell Biol       Date:  2014-09-28       Impact factor: 28.824

3.  Global evaluation of Eph receptors and ephrins in lung adenocarcinomas identifies EphA4 as an inhibitor of cell migration and invasion.

Authors:  Pierre Saintigny; Shaohua Peng; Li Zhang; Banibrata Sen; Ignacio I Wistuba; Scott M Lippman; Luc Girard; John D Minna; John V Heymach; Faye M Johnson
Journal:  Mol Cancer Ther       Date:  2012-07-17       Impact factor: 6.261

4.  Expression of Eph A4, Eph B2 and Eph B4 receptors in AML.

Authors:  Tomasz Wrobel; Joanna Pogrzeba; Ewa Stefanko; Marcin Wojtowicz; Bozena Jazwiec; Justyna Dzietczenia; Grzegorz Mazur; Kazimierz Kuliczkowski
Journal:  Pathol Oncol Res       Date:  2014-04-25       Impact factor: 3.201

5.  EphA4-mediated signaling regulates the aggressive phenotype of irradiation survivor colorectal cancer cells.

Authors:  Priscila Guimarães de Marcondes; Lilian Gonçalves Bastos; Julio Cesar Madureira de-Freitas-Junior; Murilo Ramos Rocha; José Andrés Morgado-Díaz
Journal:  Tumour Biol       Date:  2016-06-21

6.  Reduced expression of EphB2 is significantly associated with nodal metastasis in Chinese patients with gastric cancer.

Authors:  Guanzhen Yu; Yunshu Gao; Canrong Ni; Ying Chen; Jun Pan; Xi Wang; Zhiwei Ding; Jiejun Wang
Journal:  J Cancer Res Clin Oncol       Date:  2010-03-18       Impact factor: 4.553

7.  EPH-EPHRIN in human gastrointestinal cancers.

Authors:  Haruhiko Sugimura; Jian-Dong Wang; Hiroki Mori; Masaru Tsuboi; Kiyoko Nagura; Hisaki Igarashi; Hong Tao; Ritsuko Nakamura; Hiroko Natsume; Tomoaki Kahyo; Kazuya Shinmura; Hiroyuki Konno; Yasushi Hamaya; Shigeru Kanaoka; Hideki Kataoka; Xiao-Jun Zhou
Journal:  World J Gastrointest Oncol       Date:  2010-12-15

Review 8.  Clinical relevance of Ephs and ephrins in cancer: lessons from breast, colorectal, and lung cancer profiling.

Authors:  Dana M Brantley-Sieders
Journal:  Semin Cell Dev Biol       Date:  2011-10-21       Impact factor: 7.727

Review 9.  Targeted nanoparticles for colorectal cancer.

Authors:  Bruno A Cisterna; Nazila Kamaly; Won Il Choi; Ali Tavakkoli; Omid C Farokhzad; Cristian Vilos
Journal:  Nanomedicine (Lond)       Date:  2016-08-16       Impact factor: 5.307

10.  Clinical Significance of EphB4 and EphB6 Expression in Human Malignant and Benign Thyroid Lesions.

Authors:  Constantinos Giaginis; Paraskevi Alexandrou; Elpida Poulaki; Ioanna Delladetsima; Constantinos Troungos; Efstratios Patsouris; Stamatios Theocharis
Journal:  Pathol Oncol Res       Date:  2015-07-30       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.